The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$20.96

Today's change-0.07 -0.33%
Updated November 23 4:00 PM EST. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$20.96

Today's change-0.07 -0.33%
Updated November 23 4:00 PM EST. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc down $0.07

Valeant Pharmaceuticals International Inc closed lower Thursday, dropping $0.07 or 0.33% to $20.96. Over the last five days, shares have gained 14.66% and 7.65% year to date. Shares have underperformed the S&P TSX by 14.86% during the last year.

Key company metrics

  • Trailing P/E4.23×
  • P/E 1 year forward5.44×
  • Forward PEG0.82×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$4.96
Updated November 23 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue2,2192,2332,1092,403
Total other revenue--------
Total revenue2,2192,2332,1092,403
Gross profit1,5601,5871,5131,737
Total cost of revenue659646596665
Total operating expense2,1822,0581,9622,252
Selling / general / administrative623659661665
Research & development81949693
Depreciation / amortization657623635284
Interest expense (income), net operating--------
Unusual expense (income)16238-27453
Other operating expenses, total0-2193
Operating income37175147150
Interest income (expense), net non-operating-459-459-474-467
Gain (loss) on sale of assets--------
Other--------
Income before tax-400-242-295-360
Income after tax1,300-37629-512
Income tax, total-1,700-205-924152
Net income1,301-38628-515
Total adjustments to net income--------
Net income before extra. items1,301-38628-515
Minority interest1-1-1-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,301-38628-515
Inc. avail. to common incl. extra. items1,301-38628-515
Diluted net income1,301-38628-515
Dilution adjustment0------
Diluted weighted average shares352350351350
Diluted EPS excluding extraordinary itemsvalue per share3.69-0.111.79-1.47
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share3.99-0.041.75-0.65